24/7
Buzz
Startups
VC
@work
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
DataTech
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
NeuroDerm
Tags search
HOME
24/7
buzz
STARTUPS
VC
Tech@work
Innovation
OPINIONS
EVENTS
ABOUT
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:49
Full list of Israeli high-tech funding rounds in 2023
21:42
Backslash Security secures $8 million to equip AppSec teams with control over cloud-native applications
17:00
daily.dev raises $11 million in Seed funding to build a professional network for developers
12:15
"Only when women see themselves as decision makers of the future, will their situation change”
More stories
Buzz
Most popular
Daily
Weekly
1
"Investments in Israel have all but disappeared - also because of the judicial coup”
2
Israeli startup raises $11 million to use generative AI to help developers test their code
3
Full list of Israeli high-tech funding rounds in 2023
4
Check Point tells employees no raises in 2023
5
daily.dev raises $11 million in Seed funding to build a professional network for developers
More news
NeuroDerm
3 stories about NeuroDerm
After a Two-Years Slump, Israeli Tech M&A, IPOs, Up 110%
27.12.17
|
Amarelle Wenkert
U.S. buyers accounted for the majority of deals in 2017, with as many as 33 deals valued at $4.1 billion, according to a new report
Mitsubishi Tanabe Pharma Finalizes $1.1 Billion Buy of Israel-Based NeuroDerm
19.10.17
|
Lilach Baumer
NeuroDerm is looking to bring major change to Parkinson patients with its drug reformulation
Mitsubishi Tanabe Pharma to Buy Israel-Based NeuroDerm for $1.1 Billion
25.07.17
|
Gil Kalian
Osaka-based Mitsubishi Tanabe said it expects the deal would help it achieve sales of over $700 million in the U.S. by 2020
Please ensure Javascript is enabled for purposes of
website accessibility